Hot Selling Pharmaceutical Powder CAS 75330-75-5 Lovastatin

• Customization: Available
• Function: Blood System Agents
• Certification: GMP, FDA
• Model NO.: USP36/CP2015
• Grade Standard: Medicine Grade
• Type: Analysis reagent
• State: Solid
• Volatile: Not Volatile
• CAS: 75330-75-5
• appearance: White Powder
• Transport Package: 20kg/Drum
• Specification: USP36/CP2015
• Trademark: SINOAH
• Origin: China
• HS Code: 3001200090
• Production Capacity: 0.5mt/Month

Product Description

Hot selling Pharmaceutical Powder CAS 75330-75-5 Lovastatin for Antiarrhythmic
 

Quick Details:
 

Product Name	Lovastatin
Alias	Lovastatin
CAS	75330-75-5
MF	C24H36O5
MW	404.54
Purity	99%
Appearance	White powder
Certification	ISO 9001, USP, BP
Standard	Enterprise Standard
Usage    Lovastatin (mevinolin)	is a metabolite first isolated from Monascus ruber and later found in several other fungal species. Lovastatin is a potent inhibitor of HMG-CoA. HMG-CoA reductase is the rate-controlling enzyme of the mevalonate pathway, responsible for the biosynthesis of cholesterol. Lovastatin was developed as a drug as a hypolipemic agent.
Packing	Discreet packing ways as your requirement, 100% go through
Storage	Store in cool and dry area and keep away from direct sunlight

Description:

Lovastatin (Merck's Mevacor) is a member of the drug class of statins, used in combination with diet, weight-loss, and exercise for lowering cholesterol (hypolipidemic agent) in those with hypercholesterolemia to reduce risk of cardiovascular disease. Lovastatin is a naturally occurring drug found in food such as oyster mushrooms and red yeast rice.


Usage:
 
1. It is as a novel lipid regulating drugs-The inhibitor of HMG-CoA (β-hydroxy, β-methyl-glutaryl coenzyme A) reductase. It can significantly reduced serum total cholesterol level. After oral administration, it is hydrolyzed into corresponding β-hydroxy acid by 3-hydroxy-3-methylglutaryl coenzyme A reductase, and thus inhibiting the cholesterol biosynthesis. It is clinically used for treating heterozygous familial hypercholesterolemia, severe or mild hypercholesterolemia and light. It can also as an ancillary drug of dietary treatment for reducing the levels of excessively cholesterol and low-density protein cholesterol.
 
2. It is a cardiovascular systematic drug which can prevent the development of atherosclerosis and reduce the risk of myocardial infarction.
 
3.It is used for treating heterozygous familial and non familial, secondary hyperlipidemia, namely diabetes and nephrotic syndrome secondary hypercholesterolemia. It can reduce the level of TC, LF, LDL-C, and increase the level of HDL-C, reduce the risk of myocardial infarction, unstable angina and the necessity for percutaneous transluminal coronary angioplasty (PTCA).